ArriVent BioPharma Stock Forecast

Stock Price Forecast

The 11 analysts that cover ArriVent BioPharma stock have a consensus rating of "Strong Buy" and an average price target of $42.18, which forecasts a 35.85% increase in the stock price over the next year. The lowest target is $32 and the highest is $50.

Price Target: $42.18 (+35.85%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$32	$42.18	$44	$50
Change	+3.06%	+35.85%	+41.71%	+61.03%

Analyst Ratings

The average analyst rating for ArriVent BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	8	9	9	9	10	10
Buy	1	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	11	11	11	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $33 → $45	Strong Buy	Maintains	$33 → $45	+44.93%	Apr 24, 2026
Kalpit Patel B. Riley Securities	B. Riley Securities	Strong Buy Maintains $37 → $45	Strong Buy	Maintains	$37 → $45	+44.93%	Mar 23, 2026
Jeet Mukherjee BTIG	BTIG	Strong Buy Initiates $42	Strong Buy	Initiates	$42	+35.27%	Mar 12, 2026
Jeff Jones Oppenheimer	Oppenheimer	Buy Reiterates $44 → $50	Buy	Reiterates	$44 → $50	+61.03%	Mar 6, 2026
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $31 → $33	Strong Buy	Maintains	$31 → $33	+6.28%	Mar 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

47.09M

EPS This Year

-3.83

from -4.32

EPS Next Year

-3.31

from -3.83

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	47.09M
Revenue Growth	-	-	-	-	-	-	-
EPS	-96.75	-28.90	-32.38	-2.56	-4.32	-3.83	-3.31
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	84.4M
Avg	n/a	47.1M
Low	n/a	20.8M

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-3.20	-2.45
Avg	-3.83	-3.31
Low	-4.60	-4.86

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.